A 48 y old woman with unremarkable medical history was admitted with bilateral pleural effusions; even though the fluid was drained, it re-accumulated and necessitated many repeated drainages in the following 2.5 y (56 hospitalisations). The patient underwent an extensive diagnostic work-up that disclosed elevated serum antinuclear antibodies, serum anti-dsDNA antibodies, pleural fluid anti-dsDNA and decreased pleural fluid C3 and C4. During that period she has been treated with a variety of immunomodulating agents, several pleural talcage and pleurectomy, without any apparent response. Thereafter, she received six courses of IVIg (2 g/kg body weight) in monthly intervals, followed by four months treatment with cyclosporin. This treatment resulted in gradual and eventually complete disappearance of the pleural effusion, and now after more than 2 y the patient is free of symptoms and receives no further medications.
Sherer Y , Shoenfeld Y.Stem cells transplantation—a cure for autoimmune diseases . Lupus1998; 7: 137–140 .
2.
Marmont AM , van Lint MT , Gualandi F , Bacigalupo A.Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration . Lupus1997; 6: 545–548 .
3.
Schroeder JO , Zeuner RA , Euler HH , Loffler H.High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study . J Rheumatol1996; 23: 71–75 .
4.
Francioni C , Galeazzi M , Fioravanti A et al. Long term I.V.Ig treatment in systemic lupus erythematosus . Clin Exp Rheum1994; 12: 163–168 .
5.
Puddu P , De Pita O , Ruffeli M et al. Intravenous immunoglobulin therapy: modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus . Arthritis Rheum1996; 39: 704–708 .
Akashi K , Nagasawa K , Maxumi T et al. Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins . J Rheumatol1990; 17: 375–379 .
8.
Ben-Chetrit E , Putterman C , Naparstek Y.Lupus refractory pleural effusion: transient response to intravenous immunoglobulins . J Rheumatol1991; 18: 1635–1637 .
9.
Hjortkjoer Petersen H , Petersen H , Nielsen E , Hansen M et al. Highdose immunoglobulin therapy in pericarditis caused by SLE . Scand J Rheumatol1990; 19: 91–93 .
10.
Oliet A , Hernandez E , Gallar P , Vigil A.High-dose intravenous gamma-globulin in systemic lupus erythematosus . Nephron1992; 62: 465-465 (letter).
11.
Aharon A , Levy Y , Bar-Dayan Y et al. Successful treatment of early secondary myelofibrosis in SLE with IVIG . Lupus1997; 6: 408–411 .
12.
Winder A , Molad Y , Ostfeld I et al. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases . J Rheumatol1993; 20: 495–498 .
13.
Ilan Y , Naparstek Y.Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin . Acta Haematol1993; 89: 152–154 .
14.
Bingisser R , Speich R , Fontana A et al. Lupus erythematosus and Miller-Fisher syndrome . Arch Neurol1994; 51: 828–830 .
15.
Aharon A , Zandman-Goddard G , Shoenfeld Y.Autoimmune multiorgan involvement in elderly men is it SLE?Clin Rheumatol1994; 13: 631–634 .
16.
Strufelt G , Mousa F , Jonsson H et al. Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus . Ann Rheum Dis1990; 49: 939–941 .
17.
Roldan R , Roman J , Lopez D et al. Treatment of hemolytic anemia and severe thrombocytopenia with high-dose methylprednisolone and intravenous immunoglobulins in SLE . Scand J Rheumatol1994; 23: 218–219 .
18.
Ruiz-Valverde MP , Segarra A , Tovar JL , Piera L.Treatment of systemic lupus erythematosus-associated thrombocytopenia with intravenous gamma globulin . Nephron1994; 67: 500–501 .
19.
Becker BN , Fuchs H , Hakim R.Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease . J Am Soc Nephrol1995; 5: 1746–1750 .
20.
Tomer Y , Shoenfeld Y.Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin . Clin Exp Rheumatol1992; 10: 391–393 .
21.
Welch TR , McAdams AJ , Beischel LS.Glomerulonephritis associated with complete deficiency of the fourth component of complement . Response to intravenous immunoglobulin. Arthritis Rheum1995; 38: 1333–1337 .
22.
Gaedicke G , Teller WM , Kohne E et al. IgG therapy in systemic lupus erythematosus—two case reports . Blut1984; 48: 387–390 .
23.
Lesprit P , Mouloud F , Bierling P et al. Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin . Scand J Rheumatol1996; 25: 177–179 .
24.
Lafferty TE , Smith JB , Schuster SJ , DeHoratius RJ.Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus . Arthritis Rheum1997; 40: 775–778 .
25.
Disla E , Rhim HR , Reddy A et al. Reversible cardiogenic shock in a patient with lupus myocarditis . J Rheumatol1993; 20: 2174-2174 (letter).
26.
Bakimer R , Guilburd B , Zurgil N , Shoenfeld Y.The effect of intravenous g-globulin on the induction of experimental antiphospholipid syndrome . Clin Immunol Immunopathol1993; 69: 97–102 .
27.
Krause I , Blank M , Kopolovic J et al. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin . J Rheumatol1995; 22: 1068–1074 .
28.
Sugiyama M , Ogasawara H , Kaneko H et al. Effect of extremely low dose cyclosporin treatment on the thrombocytopenia in systemic lupus erythematosus . Lupus1998; 7: 53–56 .
29.
Dostal C , Tesar V , Rychlik I et al. Effect of 1 year cyclosporin treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study . Lupus1998; 7: 29–36 .
30.
Caccavo D , Laguna B , Mitterhofer AP et al. Long-term treatment of systemic lupus erythematosus with cyclosporin A . Arthritis Rheum1997; 40: 27–35 .
31.
Manger K , Kalden JR , Manger B.Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study . Br J Rheumatol1996; 35: 669–675 .
32.
Blank M , Ben-Bassat M , Shoenfeld Y.The effect of cyclosporin A on early and late stages of experimental lupus . Arthritis Rheum1992; 35: 1350–1355 .
33.
Hernandez Perez J , Fernandez Fernandez J , Sanz Moreno C et al. Primary ascites as the presenting feature of systemic lupus erythematosus: response to cyclosporin therapy . Nephrol Dial Transplant1995; 10: 1451–1453 .
34.
Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271–1277 .
